Improving maintenance treatment adherence for adults with eosinophilic esophagitis
Official title: An Intervention Study to Improve Therapeutic Compliance in Adult Patients With Eosinophilic Esophagitis.
Run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · NCT05730933 · Data updated 2026-11-12
This project will test whether extra education plus more frequent follow-up and reminders help adults with eosinophilic esophagitis stick to their long-term medications.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 72 (estimated) |
| Sponsor | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Academic / other |
| Locations | 1 site (Amsterdam) |
| Status | Recruiting |
| Started | April 12, 2023 |
| Main results expected | December 2025 |
| Study ends | December 2025 |
| Registry record updated | May 31, 2025 |
| Trial ID | NCT05730933 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) with biopsy-confirmed eosinophilic esophagitis (>15 eos/hpf) who are currently on or about to start PPI or swallowed topical corticosteroid maintenance therapy.
✕Probably not a fit
Patients who require esophageal dilation, have severe unstable comorbidities, are receiving other investigational treatments, or cannot read Dutch or English are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Investigators will test whether providing extra education combined with more frequent follow-up visits and patient reminders improves long-term adherence to maintenance medication in adults with eosinophilic esophagitis. Eligible participants are adults with histologically confirmed EoE (>15 eosinophils per high power field) who are on or starting maintenance therapy with a proton pump inhibitor or swallowed topical corticosteroids. The intervention offers additional education, closer monitoring, and reminder prompts while the comparator receives usual care and standard information. Adherence will be tracked over time using medication records and follow-up contacts to determine whether the enhanced support increases persistence with therapy.
Why it matters
Potential benefit: If successful, this approach could help patients stay on maintenance medication more consistently, reducing symptoms and the risk of complications or urgent care visits.
How similar studies have gone: Behavioral, educational, and reminder-based programs have improved medication adherence in many chronic diseases, but direct evidence in eosinophilic esophagitis is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Written informed consent * Male or female patient * Age \>18 years * Previous diagnosis of EoE, confirmed by histopathology, with the presence of \>15 eosinophilic granulocytes per high power field (hpf) in esophageal biopsies * Current maintenance treatment for EoE with a PPI or swallowed topical corticosteroids or about to start with these maintenance medications as decided during regular clinical practice Exclusion Criteria: * Severe and clinically unstable concomitant disease that may interfere with the subject's ability to participate in the study * Receive investigational treatment during the study * Dilation of esophagus required * Insufficient Dutch or English language skills to understand patient information leaflets
Where it's running
-
Amsterdam UMC, location AMC
Amsterdam, Netherlands Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Upadacitinib for Eosinophilic Esophagitis in adults not responding to standard therapy
This study tests whether upadacitinib, taken with topical corticosteroids, can reduce disease activity in adults with eosinophilic esophagitis who still have symptoms.
-
A registry for adults with esophageal movement and reflux problems.
This project will collect esophageal function tests (manometry, pH-impedance, FLIP) and clinical data from adults with reflux or swallowing symptoms to see if combining these results helps guide diagnosis and long-term care.
-
Using a mucosal impedance device to help diagnose chronic esophageal problems
This test tries a mucosal impedance device during upper endoscopy to see if it helps diagnose people with chronic reflux (GERD) or eosinophilic esophagitis.
-
Esophageal string test to screen for eosinophilic esophagitis in adults of African descent with swallowing problems
This study will test whether a 1-hour esophageal string test can detect eosinophilic esophagitis in adults born in Africa (or with African parents) who have trouble swallowing.
-
Improving management of eosinophilic esophagitis in children and adolescents
This study is trying to find better ways to manage eosinophilic esophagitis in kids and teens by using simple tests to avoid invasive procedures and improve their quality of life.
-
How common FIRE is and what it looks like in children with eosinophilic esophagitis
This project will see how often and in what ways Food Induced Immediate Response of the Esophagus (FIRE) occurs in children aged 6–17 who have eosinophilic esophagitis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.